Showing 1 - 3 results of 3 for search 'L. A. Ruyatkina', query time: 0.01s
Refine Results
-
1
The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution by M. V. Shestakova, G. R. Galstyan, E. N. Grineva, A. V. Zilov, T. Yu. Demidova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, O. Y. Sukhareva, L. A. Suplotova, M. S. Shamkhalova
Published 2023-11-01Get full text
Article -
2
THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES by M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov
Published 2016-05-01Get full text
Article -
3
Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board by M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, T. P. Bardymova, F. V. Valeeva, G. R. Galstyan, T. Yu. Demidova, I. A. Karpova, T. P. Kiseleva, A. Yu. Mayorov, A. M. Mkrtumyan, S. V. Nedogoda, N. А. Petunina, L. A. Ruyatkina, L. A. Suplotova, O. Yu. Sukhareva, V. V. Fadeev, M. S. Shamkhalova
Published 2022-01-01Get full text
Article